07-150-12 MIZUHO, MINI, SLIM, STERILE, BOX OF 4, REF 138665 The Doppler probe is intended for ...

FDA Device Recall #Z-2000-2014 — Class II — May 28, 2014

Recall Summary

Recall Number Z-2000-2014
Classification Class II — Moderate risk
Date Initiated May 28, 2014
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Vascular Technology, Inc.
Location Nashua, NH
Product Type Devices
Quantity 34

Product Description

07-150-12 MIZUHO, MINI, SLIM, STERILE, BOX OF 4, REF 138665 The Doppler probe is intended for the intraoperative and transcutaneous evaluation of blood flow.

Reason for Recall

Report of the product penetrating the sterile barrier; this could render the product unsterile.

Distribution Pattern

Worldwide Distribution - US including California and the countries of Australia, United Kingdom and Taiwan.

Lot / Code Information

LOT NUMBER 1516-37698

Other Recalls from Vascular Technology, Inc.

Recall # Classification Product Date
Z-3026-2018 Class II VTI 8 MHz Surgical Doppler Transceiver Selectab... Jun 19, 2018
Z-1998-2014 Class II 07-150-07 MIZUHO, MAL DISP DOPPLER PROBE BX 4, ... May 28, 2014
Z-1999-2014 Class II 07-150-10 MIZUHO, DOPPLER PROBE, SLIM, BX 4, RE... May 28, 2014
Z-2001-2014 Class II VTI BAYONET DOPPLER, 20MHz DOPPLER PROBE, SLIM,... May 28, 2014

Frequently Asked Questions

Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.